血管腔内修复时机对急性Stanford B型主动脉夹层预后影响的系统评价与Meta分析
该系统评价与Meta分析检索EMBASE、PubMed和Cochrane Library至2023年12月,纳入25项研究共4,827例急性Stanford B型主动脉夹层患者(其中亚急性期1,609例),比较急性期(14天内)与亚急性期(14-90天)行胸主动脉腔内修复(TEVAR)的结局。亚急性期TEVAR的Ia型内漏和主动脉破裂发生率较低,而急性期TEVAR的逆行性夹层、远端支架诱导新发破口和再干预率显著较高。
要点
- 亚急性期TEVAR的Ia型内漏发生率低于急性期(OR 1.55,95%CI 1.03-2.33,P=0.04)。
- 急性期TEVAR的逆行性夹层(OR 2.12,95%CI 1.04-4.34,P=0.04)和远端支架诱导新发破口(OR 2.39,95%CI 1.24-4.61,P=0.009)发生率高于亚急性期。
- 两组假腔血栓形成和真腔回缩结果相当。
核心结论
- 亚急性期行TEVAR较急性期即刻治疗能更有效降低不良事件发生率。
研究设计与样本
- 系统评价与Meta分析,检索EMBASE、PubMed和Cochrane Library至2023年12月,纳入25项研究共4,827例急性Stanford B型主动脉夹层患者(其中亚急性期1,609例),采用随机效应模型或固定效应模型估计OR及95%CI。
主要发现
- 早期结果:亚急性期TBAD的Ia型内漏发生率较低(OR 1.55,95%CI 1.03-2.33,P=0.04),主动脉破裂发生率较低(OR 2.89,95%CI 0.98-8.50,P=0.05),其余事件两组差异不大。
- 晚期结果:急性期TBAD的逆行性夹层发生率显著较高(OR 2.12,95%CI 1.04-4.34,P=0.04),远端支架诱导新发破口发生率显著较高(OR 2.39,95%CI 1.24-4.61,P=0.009),再干预率显著较高(OR 1.45,95%CI 0.05-1.99,P=0.02),其余结局两组无显著差异。
- TEVAR在两组中对于假腔血栓形成和真腔回缩的结果似乎相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to determine whether thoracic endovascular aortic repair (TEVAR) timing is more beneficial in the acute phase (first 14 days) than in the subacute phase (14-90 days) for the administration of acute Stanford type B aortic dissection (TBAD). METHODS: A comprehensive literature search was conducted in databases (EMBASE, PubMed and Cochrane Library) until December 2023 to identify studies reporting the results of TEVAR used for patients with acute TBAD. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated utilizing either the random-effects model or the fixed-effects model. RESULTS: A total of 25 studies involving 4,827 individuals with TBAD (including 1,609 with subacute TBAD) met our selection criteria. Early results revealed a lower incidence of Ia endoleaks (OR, 1.55; 95% CI, 1.03-2.33; P = 0.04) and aortic ruptures (OR, 2.89; 95% CI, 0.98-8.50; P = 0.05) in subacute TBAD. Apart from these findings, there was little difference in other incidents between the 2 groups. Regarding late outcomes, we observed significantly higher rates of retrograde dissection (OR, 2.12; 95% CI, 1.04-4.34; P = 0.04), distal stent-induced new entry (OR, 2.39; 95% CI, 1.24-4.61; P = 0.009), and reintervention (OR, 1.45; 95% CI, 0.05-1.99; P = 0.02) in acute TBAD than in subacute TBAD, whereas no significant differences were found for other outcomes between the 2 groups. Also, TEVAR appeared to yield comparable results for false lumen thrombosis and true lumen regression in both groups. CONCLUSIONS: Subacute TBAD repair with TEVAR demonstrates a more effective reduction in adverse event rates compared to immediate treatment in the acute phase.
引用
- Wang J, Bai Z, Chen B, et al. A Systematic Review and Meta-Analysis of Current Evidence Related to the Impact of Endovascular Repair Timing on Prognosis of Acute Stanford Type B Aortic Dissection. Ann Vasc Surg. 2024. PMID: 38960090. doi:10.1016/j.avsg.2024.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。